Spirometric Indices in Type 2 Diabetes Mellitus Patients in a Nigerian Tertiary Institution


  •   Adekunle O. Adeoti

  •   Taiwo H. Raimi

  •   Joseph O. Fadare

  •   Raphael Ibidapo


Background: Diabetes mellitus is a non-communicable disease of global health importance. It is a metabolic disorder caused by increased levels of blood glucose over a prolonged period of time. Type 2 diabetes mellitus (T2DM) is usually associated with obesity and insulin resistance. Several studies have also revealed that diabetes mellitus hampers pulmonary functions. This study was aimed at estimating the spirometric indices in type 2 diabetes mellitus patients.

Methods: A cross-sectional study of T2DM patients and apparently healthy control attending the medical outpatient clinic in a tertiary institution in south western Nigeria.

Results: A total of 146 participants with 73 patients with T2DM and 73 control groups. There were no significant differences in the age, body mass index, and gender distribution of the diabetics and control. However, patients with diabetes had higher SBP (133.2±20.17 mmHg vs 111.6±6.5 mmHg p<0.0001), and DBP (78.4±11.8mmHg vs 73.7±6.3 mmHg, p=0.003) when compared to the control. The mean FEV (1.98±0.5 vs 2.09±1.2, p=0.033), FVC (2.35±0.6 vs 2.53±1.3, p=0.045) and FEV/FVC ratio (83.61±7.2 vs 81.14±10.7, p=0.029) were significantly lower in diabetic patients when compared to matched controls. There was no significant difference in the PEF and FEF of both groups.

Conclusion: Type 2 diabetes mellitus patients had significant decrease in their spirometric indices, hence pulmonary function should be included in the periodic comprehensive diabetic check for holistic management.

Keywords: Pulmonary function, Spirometric indices, Diabetes Mellitus, Non-communicable diseases


A. M. Ahmed. History of diabetes mellitus. Saudi Med J, vol. 23, no. 4, pp. 373-378. 2002.

H. W. Baynest. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. Journal of Diabetes & Metabolism, vol. 06, no., pp. 2015.

N. H. Cho, J. E. Shaw, S. Karuranga, Y. Huang, J. D. da Rocha Fernandes, A. W. Ohlrogge, B. Malanda. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, vol. 138, no., pp. 271-281. 2018.

D. Pitocco, L. Fuso, E. G. Conte, F. Zaccardi, C. Condoluci, G. Scavone, R. A. Incalzi, G. Ghirlanda. The diabetic lung--a new target organ? Rev Diabet Stud, vol. 9, no. 1, pp. 23-35. 2012.

W.H.O. Diabetes Fact sheet N312. Geneva: World Health Organization; 2018.

DMICC. Genetic basis of type 1 and type2 diabetes, obesity, and their complications.: DMICC; 2014.

R. N. Oputa, S. Chinenye. Diabetes in Nigeria – a translational medicine approach. African Journal of Diabetes Medicine, vol. 23, no. 1, pp. 7-11. 2015.

A. E. Uloko, B. M. Musa, M. A. Ramalan, I. D. Gezawa, F. H. Puepet, A. T. Uloko, M. M. Borodo, K. B. Sada. Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Ther, vol. 9, no. 3, pp. 1307-1316. 2018.

S. Ljubic, Z. Metelko, N. Car, G. Roglic, Z. Drazic. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest, vol. 114, no. 4, pp. 1033-1035. 1998.

E. Ofoegbu, S. Chinenye. National Clinical Practice Guidelines for Diabetes Management in Nigeria. Diabetes Association of Nigeria (DAN), vol., no., pp. 2013.

V. P. Singh, A. Bali, N. Singh, A. S. Jaggi. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol, vol. 18, no. 1, pp. 1-14. 2014.

United Nations General Assembly. Declaration 61/295 on the Rights of Indigenous Peoples. New york: United nations; 2008.

M. Sandler. Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med, vol. 150, no. 7, pp. 1385-1388. 1990.

J. Giovannelli, P. Trouiller, S. Hulo, N. Cherot-Kornobis, A. Ciuchete, J. L. Edme, R. Matran, P. Amouyel, A. Meirhaeghe, L. Dauchet. Low-grade systemic inflammation: a partial mediator of the relationship between diabetes and lung function. Ann Epidemiol, vol. 28, no. 1, pp. 26-32. 2018.

O. L. Klein, J. A. Krishnan, S. Glick, L. J. Smith. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med, vol. 27, no. 9, pp. 977-987. 2010.

G. Sagun, C. Gedik, E. Ekiz, E. Karagoz, M. Takir, A. Oguz. The relation between insulin resistance and lung function: a cross sectional study. BMC Pulm Med, vol. 15, no., pp. 139. 2015.

I. Vanidassane, R. Malik, N. Jain. Study of Pulmonary function tests in Type 2 Diabetes Mellitus and their correlation with glycemic control and systemic inflammation. Adv Respir Med, vol., no., pp. 2018.

C. A. Benbassat, E. Stern, M. Kramer, J. Lebzelter, I. Blum, G. Fink. Pulmonary function in patients with diabetes mellitus. Am J Med Sci, vol. 322, no. 3, pp. 127-132. 2001.

https://select-statistics.co.uk/contact-us/. vol., no., pp.

O. Adeyeye, A. Ogbera. Correlates of Abnormal Lung Functions in Type 2 Diabetes in Lagos, Nigeria. CHEST, vol. 146, no. 4, pp. 806A. 2014.

W.H.O. Obesity: preventing and managing the global epidemic.Report of a WHO consultation. Geneva: World Health Organization; 2000.

M. R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C. P. van der Grinten, P. Gustafsson, R. Jensen, D. C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O. F. Pedersen, R. Pellegrino, G. Viegi, J. Wanger, A. E. T. Force. Standardisation of spirometry. Eur Respir J, vol. 26, no. 2, pp. 319-338. 2005.

A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo, Jr., D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright, Jr., E. J. Roccella, D. E. Joint National Committee on Prevention, L. Treatment of High Blood Pressure. National Heart, I. Blood, C. National High Blood Pressure Education Program Coordinating. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, vol. 42, no. 6, pp. 1206-1252. 2003.

Z. Anwer, R. K. Sharma, V. K. Garg, N. Kumar, A. Kumari. Hypertension management in diabetic patients. Eur Rev Med Pharmacol Sci, vol. 15, no. 11, pp. 1256-1263. 2011.

C. Arauz-Pacheco, M. A. Parrott, P. Raskin. The treatment of hypertension in adult patients with diabetes. Diabetes Care, vol. 25, no. 1, pp. 134-147. 2002.

G. L. Bakris, M. Williams, L. Dworkin, W. J. Elliott, M. Epstein, R. Toto, K. Tuttle, J. Douglas, W. Hsueh, J. Sowers. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis, vol. 36, no. 3, pp. 646-661. 2000.

S. F. Akram, E. Asharaf, S. H. Masood, S. M. M. Ali. Association of Pulmonary Functions and HbA1c in Diabetics. PJMHS, vol. 7, no. 2, pp. 306 -309. 2013.

J. Zheng, J. Cheng, T. Wang, Q. Zhang, X. Xiao. Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis. Int J Endocrinol, vol. 2017, no., pp. 1537213. 2017.

W. A. Davis, M. Knuiman, P. Kendall, V. Grange, T. M. Davis, S. Fremantle Diabetes. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care, vol. 27, no. 3, pp. 752-757. 2004.

M. D. Goldman. Lung dysfunction in diabetes. Diabetes Care, vol. 26, no. 6, pp. 1915-1918. 2003.

M. Irfan, A. Jabbar, A. S. Haque, S. Awan, S. F. Hussain. Pulmonary functions in patients with diabetes mellitus. Lung India, vol. 28, no. 2, pp. 89-92. 2011.

S. A. Meo, A. M. Al-Drees, M. Arif, K. Al-Rubean. Lung function in type 2 Saudi diabetic patients. Saudi Med J, vol. 27, no. 3, pp. 338-343. 2006.

N. Agarwal, S. Kaur. Pulmonary function tests in type 2 diabetes mellitus. Archives of Medicine and Health Sciences, vol. 4, no. 1, pp. 2016.

S. M. S. Anandhalakshmi, Ganeshkumar, P, Ramachandran, C. Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus. J Clin Diagn Res, vol. 7, no. 9, pp. 1874-1877. 2013.

Aparna. Pulmonary function tests in type 2 diabetics and non-diabetic people -a comparative study. J Clin Diagn Res, vol. 7, no. 8, pp. 1606-1608. 2013.

H. Huang, Q. Guo, L. Li, S. Lin, Y. Lin, X. Gong, J. Yao, J. Liang, L. Lin, J. Wen, G. Chen. Effect of type 2 diabetes mellitus on pulmonary function. Exp Clin Endocrinol Diabetes, vol. 122, no. 6, pp. 322-326. 2014.

H. Y. Kim, T. S. Sohn, H. Seok, C. D. Yeo, Y. S. Kim, J. Y. Song, Y. B. Lee, D. H. Lee, J. I. Lee, T. K. Lee, S. C. Jeong, M. Hong, H. S. Chae. Prevalence and risk factors for reduced pulmonary function in diabetic patients: The Korea National Health and Nutrition Examination Survey. Korean J Intern Med, vol. 32, no. 4, pp. 682-689. 2017.

F. Innocenti, A. Fabbri, R. Anichini, S. Tuci, G. Pettina, F. Vannucci, L. A. De Giorgio, G. Seghieri. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract, vol. 25, no. 3, pp. 161-168. 1994.

T. Soulis, V. Thallas, S. Youssef, R. E. Gilbert, B. G. McWilliam, R. P. Murray-McIntosh, M. E. Cooper. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia, vol. 40, no. 6, pp. 619-628. 1997.

S. G. Keerthi, B. Sharan, M. Singh, H. K. Bandi, J. K. Preetham. Deterioration of Pulmonary Functions in Type 2 Diabetes Mellitus. Journal of Pharmacy and Biological Sciences, vol. 1, no. 1, pp. 39-43. 2012.

C. K. Sreeja, E. Samuel, C. Kesavachandran, S. Shashidhar. Pulmonary function in patients with diabetes mellitus. Indian J Physiol Pharmacol, vol. 47, no. 1, pp. 87-93. 2003.


Download data is not yet available.


How to Cite
Adeoti, A. O., Raimi, T. H., Fadare, J. O., & Ibidapo, R. (2021). Spirometric Indices in Type 2 Diabetes Mellitus Patients in a Nigerian Tertiary Institution. European Journal of Medical and Health Sciences, 3(3), 10-14. https://doi.org/10.24018/ejmed.2021.3.3.293